Dr. Knelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Merck Research Labs
Boston, MA 02115
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 2015 - 2017
Duke University School of MedicineClass of 2015
Certifications & Licensure
MA State Medical License 2015 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 263 citationsTreatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.Kari J. Kurppa, Yao Liu, Ciric To, Tinghu Zhang, Mengyang Fan
Cancer Cell. 2020-01-13 - 12 citationsMET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.Ryohei Yoshida, Maria Saigi, Tetsuo Tani, Benjamin F Springer, Hirofumi Shibata
Cancer Research. 2022-11-02 - 20 citationsSurgical and Peri-Operative Considerations for Brain Metastases.Saksham Gupta, Hassan Y. Dawood, Alexandra M Giantini Larsen, Luis Fandino, Erik H. Knelson
Frontiers in Oncology. 2021-05-05
Authored Content
- Type III TGF-Β Receptor Promotes FGF2-Mediated Neuronal Differentiation in NeuroblastomaOctober 2013
Press Mentions
Drs. Erik Knelson, Dwight Owen, and Erin Schenk Receive 10th Annual LUNGevity Career Development AwardsSeptember 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
